Skip to main content

Nurix Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update

Enrolling Phase 2 DAYBreak CLL-201 bexobrutideg trial designed to support Accelerated Approval in relapsed/refractory chronic lymphocytic leukemia (r/r CLL) Enabling Phase 3 DAYBreak CLL-306 bexobrutideg confirmatory trial for full approval in r/r CLL Targeting 2026 IND submission for bexobrutideg in inflammatory and autoimmune indications with a new tablet formulation Continuing advancement of targeted protein degraders of IRAK4 in Phase 1 and STAT6 in IND-enabling studies under strategic partnerships Well capitalized with $540.7 million on the balance sheet BRISBANE, Calif., April 08, 2026 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, today reported financial results for...

Continue reading

Stella-Jones’ First Quarter 2026 Results Conference Call and Annual Meeting of Shareholders

MONTRÉAL, April 08, 2026 (GLOBE NEWSWIRE) — Stella-Jones Inc. (TSX: SJ), (“Stella-Jones” or the “Company”) will hold a conference call to discuss its first quarter results:  Open to: Investors, analysts and all interested parties  Date: Wednesday, May 6, 2026  Time: 8:00 AM Eastern Daylight Time (EDT)  Live Webcast: https://meetings.lumiconnect.com/400-925-467-567  Call: Local – Toronto: +1 (416) 855-9085 Toll Free – North America: +1 (800) 990-2777 Conference ID: 85640     The press release will be published before market opens the day of the conference call through Globe Newswire. Please log on or dial in 15 minutes before the conference begins. If you are unable to attend at this time, you may access a web recording of the meeting at the following link: https://meetings.lumiconnect.com/400-925-467-567....

Continue reading

TRX Gold Reports Robust Recovery Rates from Recent Study and Significant Increase in Plant Expansion Scope

TORONTO, April 08, 2026 (GLOBE NEWSWIRE) — TRX Gold Corporation (TSX: TRX) (NYSE American: TRX) (the “Company” or “TRX Gold”) is pleased to announce results of ongoing metallurgical test work at the Buckreef Gold Project (“Buckreef Gold”) as part of its current flowsheet optimisation and future expanded processing plant development. The Company is in the process of planning and executing a much larger processing plant expansion than originally anticipated in the May 2025 Preliminary Economic Assessment (“PEA”) at Buckreef Gold.   Robust Recovery Rates Achieved: Recovery rates between 89% – 92% were achieved from the additional test work, which is in line with prior studies and above the 88% recovery rate assumed in the PEA. The test work provided a more comprehensive understanding of optimal grind size for flotation and achievable...

Continue reading

Real Messenger Announces Receipt of Nasdaq Notification Letter Regarding Stockholders’ Equity Deficiency

Costa Mesa, CA, April 08, 2026 (GLOBE NEWSWIRE) — Real Messenger Corporation (“Real Messenger” or the “Company”) (Nasdaq: RMSG), an innovative chat-based platform reimagining real estate connections, today announced that it received a notification letter from The Nasdaq Stock Market LLC (“Nasdaq”) dated April 6, 2026, notifying the Company that, based on the reported stockholders’ equity of $1,110,873 of the Company as reported in its unaudited interim financial report on Form 6-K filed with the Securities and Exchange Commission (the “SEC”) on March 31, 2026, it was no longer in compliance with the minimum stockholders’ equity requirement for continued listing on the Nasdaq Capital Market. Nasdaq Listing Rule 5550(b)(1) requires listed companies to maintain stockholders’ equity of at least $2,500,000. The Nasdaq notification does...

Continue reading

Zelluna ASA – Disclosure of voting rights of Annual General Meeting

Oslo, April 8, 2026: In connection with the Annual General Meeting of Zelluna ASA to be held on April 23, 2026, Anders Tuv, Chair of the Board of Directors, has, as of the date of this announcement, received proxy-based voting rights without voting instructions (discretionary proxies) for 2,308,791 shares, representing 8.79% of the total voting rights in the Company. The proxies are only valid for the Annual General Meeting on April 23, 2026. Shares for which advance votes have been cast are not included. This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. For further information, please contact: Anders Tuv, Chairman of the BoardEmail: at@radforsk.noPhone: +47 982 06 826 Namir Hassan, Chief Executive OfficerEmail: namir.hassan@zelluna.com Phone: +44 7720 687608 Geir...

Continue reading

Subsea 7 S.A. – First quarter 2026 earnings call notification

Luxembourg – 8 April 2026 – Subsea 7 S.A. (Oslo Børs: SUBC, ADR: SUBCY) will publish its first quarter 2026 results for the period ended 31 March 2026 on Thursday 30 April 2026 at 08:00 CEST. A conference call and simultaneous webcast for the investment community will be held on Thursday 30 April 2026 at 11:00 BST / 12:00 CEST. From 08:00 CEST the results announcement and the presentation to be reviewed during the conference call and webcast will be available on the Subsea7 website: www.subsea7.com Conference call registration:Phone:         https://register-conf.media-server.com/register/BI61977f2584e84656ba03405a9cdccd34Webcast:     https://edge.media-server.com/mmc/p/ww7yq65a/Please note that questions can only be submitted from a phone line. ******************************************************************************* Subsea7 creates...

Continue reading

SKAGI: Reglubundin tilkynning um kaup á eigin bréfum í samræmi við endurkaupaáætlun – vika 14

Í 14.  viku 2026 keypti Skagi 1.350.000 eigin hluti að kaupverði alls kr. 22.835.000 eins og hér segir:Vika Dags Tími Keyptirhlutir Viðskipta-verð Kaupverð (kr) Eigin hlutir eftir viðskiptiVika 14 30.03.2026 13:55 500.000 16.60 8.300.000 21.500.000Vika 14 01.04.2026 09:40 450.000 71,1 7.695.000 21.950.000Vika 14 07.04.2026 10:27 400.000 71,1 6.840.000 22.350.000Kaupin eru í samræmi við endurkaupaáætlun félagsins sem hrint var í framkvæmd 2. mars 2026, sbr. tilkynningu á markað 23. febrúar 2026. Áætlað er að kaupa allt að 40 milljón eigin hluti sem jafngildir um 2,06% af útgefnu hlutafé félagsins, þó þannig að heildarfjárhæð endurkaupanna verði aldrei meiri en samtals kr. 750 milljónir króna að kaupverði. Endurkaup munu standa yfir þar til öðru hvoru framangreindra viðmiða um magn eða fjárhæð er náð, en þó aldrei lengur en...

Continue reading

WENDEL: Shareholders’ Meeting set for May 21, 2026

PRESS RELEASE — APRIL 8, 2026 Shareholders’ Meeting set for May 21, 2026 Wendel informs its shareholders that the Shareholders’ Meeting will be held on Thursday May 21, 2026, at 3 p.m. (Paris time) at the Auditorium Cézanne Saint-Honoré, located at 2-4, rue Paul-Cézanne, 75008 Paris. The notice of meeting, being worth convening notice, is published today in French in the Bulletin des Annonces Légales et Obligatoires (www.journal-officiel.gouv.fr/balo/). It includes the agenda, the draft resolutions which will be presented to the Meeting and the conditions to take part in the Meeting. It is also available on the Wendel website. Other documents and information concerning this Meeting will be available to shareholders and published no later than April 30, 2026, under legal and regulatory conditions, on the dedicated page of the Wendel website...

Continue reading

LHV Group Dividend Ex-date

Pursuant to the resolution of the Annual General Meeting of AS LHV Group shareholders, LHV Group will pay a dividend of EUR 0.17 per share for the financial year 2025. In accordance with the shareholders’ resolution and the previously published financial calendar, the list of shareholders entitled to receive the dividend will be established as at the end of the Nasdaq CSD settlement system business day on 10 April 2026 (record date). Accordingly, the ex-date is 9 April 2026. From this date, acquisition of the shares does not confer the right to receive the dividend for the financial year 2025. The dividend will be paid to shareholders on 15 April 2026 (payment date). LHV Group is the largest domestic financial group and capital provider in Estonia. LHV Group’s key subsidiaries are LHV Pank, LHV Varahaldus, LHV Kindlustus, and LHV Bank...

Continue reading

Yimutian Inc. Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price

BEIJING, April 08, 2026 (GLOBE NEWSWIRE) — Yimutian Inc. (Nasdaq: YMT) (“Yimutian” or the “Company”), a leading agricultural digital service company in China, today announced that it received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) on April 2, 2026 indicating that the Company is not in compliance with the $1.00 minimum bid price requirement under the Nasdaq Listing Rules (the “Listing Rules”). Based on the closing bid price of the Company’s listed securities from February 18, 2026 to April 1, 2026, the Company has not met the minimum bid price requirement set forth in Listing Rule 5450(a)(1) during that period. The Notice is only a notification of deficiency and has no immediate effect on the listing of the Company’s American Depositary Shares (“ADS”)....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.